Examination of reproductive aging milestones among women who carry the FMR1 premutation

Human Reproduction

Volumn 22, Issue 8, 2007, Pages 2142-2152

  Allen, E Graves ^a,c   Sullivan, A K ^a   Marcus, M ^b   Small, C ^b   Dominguez, C ^a   Epstein, M P ^a   Charen, K ^a   He, W ^a   Taylor, K C ^b   Sherman, S L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

FMRP; Infertility; Menopause; RNA toxic effect; Trinucleotide

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; NUCLEOTIDE;

ADULT; AGED; AGING; ANAMNESIS; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; HETEROZYGOTE DETECTION; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NUCLEOTIDE REPEAT; OSTEOPOROSIS; OVARY INSUFFICIENCY; PREGNANCY OUTCOME; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SUBFERTILITY;

EID: 34547813683     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem148     Document Type: Article

References (45)

1. Ashley CT, Jr, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 1993;262:563-566.
2. Bachner D, Manca A, Steinbach P, Wohrle D, Just W, Vogel W, Hameister H, Poustka A. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum Mol Genet 1993;2:2043-2050.
3. Bione S, Rizzolio F, Sala C, Ricotti R, Goegan M, Manzini MC, Battaglia R, Marozzi A, Vegetti W, Dalpra L et al. Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 2004;19:2759-2766.
4. Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 1993;270:1569-1575.
5. Bussani C, Papi L, Sestini R, Baldinotti F, Bucciantini S, Bruni V, Scarselli G. Premature ovarian failure and fragile X premutation: A study on 45 women. Eur J Obstet Gynecol Reprod Biol 2004;112 189-191.
6. Conway GS, Hettiarachchi S, Murray A, Jacobs PA. Fragile X premutations in familial premature ovarian failure. Lancet 1995;346 309-310.
7. Cooper GS, Sandler DP, Bohlig M. Active and passive smoking and the occurrence of natural menopause. Epidemiology 1999;10 771-773.
8. Costa A, Wang Y, Dockendorff TC, Erdjument-Bromage H, Tempst P, Schedl P, Jongens TA. The Drosophila fragile X protein functions as a negative regulator in the orb autoregulatory pathway. Dev Cell 2005;8 331-342.
9. Crawford DC, Acuna JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 2001;3:359-371.
10. Den Tonkelaar I, Te Velde ER, Looman CW. Menstrual cycle length preceding menopause in relation to age at menopause. Maturitas 1998;29:115-123.
11. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 2006;14:253-255.
12. Fryns JP. The female and the fragile X. A study of 144 obligate female carriers. Am J Med Genet 1986;23:157-169.
13. Hagerman RJ, Hagerman PJ. The fragile X premutation: Into the phenotypic fold. Curr Opin Genet Dev 2002;12:278-283.
14. Hergersberg M, Matsuo K, Gassmann M, Schaffner W, Luscher B, Rulicke T, Aguzzi A. Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice. Hum Mol Genet 1995;4:359-366.
15. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 1993;3 36-43.
16. Hundscheid RD, Sistermans EA, Thomas CM, Braat DD, Straatman H, Kiemeney LA, Oostra BA, Smits AP. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet 2000;66:413-418.
17. Hundscheid RD, Braat DD, Kiemeney LA, Smits AP, Thomas CM. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 2001;16 457-462.
18. Hundscheid RD, Smits AP, Thomas CM, Kiemeney LA, Braat DD. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet 2003;117A:6-9.
19. Jin P, Zarnescu DC, Zhang F, Pearson CE, Lucchesi JC, Moses K, Warren ST. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 2003;39:739-747.
20. Jin P, Alisch RS, Warren ST. RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 2004;6:1048-1053.
21. Kok HS, Van Asselt KM, Van Der Schouw YT, Grobbee DE, Te Velde ER, Pearson PL, Peeters PH. Subfertility reflects accelerated ovarian ageing. Hum Reprod 2003;18:644-648.
22. Lambalk CB, De Koning CH, Braat DD. The endocrinology of dizygotic twinning in the human. Mol Cell Endocrinol 1998;145:97-102.
23. Mallolas J, Duran M, Sanchez A, Jimenez D, Castellvi-Bel S, Rife M, Mila M. Implications of the FMR1 gene in menopause: Study of 147 Spanish women. Menopause 2001;8:106-110.
24. Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, Crosignani PG, Ginelli E, Meneveri R, Dalpra L. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 2000;15:197-202.
25. Meadows KL, Pettay D, Newman J, Hersey J, Ashley AE, Sherman SL. Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet 1996;64:428-433.
26. Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35:637-640.
27. Murray A, Webb J, Macswiney F, Shipley EL, Morton NE, Conway GS. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod 1999;14 1217-1218.
28. Murray A, Ennis S, Macswiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 2000;8:247-252.
29. Nikolaou D, Templeton A. Early ovarian ageing. Eur J Obstet Gynecol Reprod Biol 2004;113:126-133.
30. Nolin SL, Brown WT, Glicksman A, Houck GE, Jr, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003;72:454-464.
31. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: Evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-1237.
32. Rife M, Nadal A, Mila M, Willemsen R. Immunohistochemical FMRP studies in a full mutated female fetus. Am J Med Genet 2004;124A 129-132.
33. Rizzolio F, Bione S, Sala C, Goegan M, Gentile M, Gregato G, Rossi E, Pramparo T, Zuffardi O, Toniolo D. Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature. Hum Reprod 2006;21:1477-1483.
34. Rossetti F, Rizzolio F, Pramparo T, Sala C, Bione S, Bernardi F, Goegan M, Zuffardi O, Toniolo D. A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet 2004;12 829-834.
35. Sherman SL, Meadows KL, Ashley AE. Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females. Am J Med Genet 1996;64:256-260.
36. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: Diagnostic and carrier testing. Genet Med 2005;7(8):584-587.
37. Sherman SL, Taylor K, Allen EG. FMR1 premutation: A leading cause of inherited ovarian dysfunction. In: Arrieta I, Penagarikano O, Telez M (eds). Fragile Sites: New Discoveries and Changing Perspectives. Nova Science Publishers, 2007.
38. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-412.
39. Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
40. Turner G, Robinson H, Wake S, Martin N. Dizygous twinning and premature menopause in fragile X syndrome. Lancet 1994;344:1500.
41. Vianna-Morgante AM. Twinning and premature ovarian failure in premutation fragile X carriers. Am J Med Genet 1999;83:326.
42. Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004;89 4569-4574.
43. Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, Nieuwenhuizen IM, Schrier M, Van Unen L, Tassone F, Hoogeveen AT et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ ataxia syndrome. Hum Mol Genet 2003;12:949-959.
44. Zarnescu DC, Jin P, Betschinger J, Nakamoto M, Wang Y, Dockendorff TC, Feng Y, Jongens TA, Sisson JC, Knoblich JA et al. Fragile X protein functions with lgl and the par complex in flies and mice. Dev Cell 2005;8:43-52.
45. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.